Efficacy and safety of the human GLP-1 analog liraglutide in combination with metformin and TZD in patients with type 2 diabetes mellitus (LEAD-4 Met+TZD)
Liu SX, Geng B, Zou LQ, Wei SN, Wang WY, Deng J, Xu C, Zhao X, Lyu Y, Su X, et al
A groundbreaking new study has revealed that tirzepatide leads to significantly greater weight loss than semaglutide in people living with obesity but without diabetes
Sikiric et al., 2020b) without toxicity (lethal dose 1 (LD1) could be not obtained) (Sikiric et al., 1993
GLP-1 Medical Programs Peptide Therapy High Protein Program FAQs Mostly Asked Questions Helping you understand our medically supervised weight loss programs, treatments, and support options so you can feel confident taking the next step toward your health goals